Phase IIa trial of inhaled sodium nitrite (AIR 001) in patients with heart failure with preserved ejection fraction.

Trial Profile

Phase IIa trial of inhaled sodium nitrite (AIR 001) in patients with heart failure with preserved ejection fraction.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Apr 2017

At a glance

  • Drugs Sodium nitrite (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jan 2016 Top-line data expected by this month, as per Mast Therapeutics media release.
    • 07 Jan 2016 Status changed from recruiting to active, no longer recruiting, as per Mast Therapeutics media release.
    • 09 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top